Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Genzyme to co-promote Afirma thyroid cancer test with Veracyte

Executive Summary

Sanofi’s Genzyme Corp. has entered into a co-promotion deal surrounding molecular cytology company Veracyte Inc.’s Afirma thyroid FNA (fine needle aspiration) analysis test for thyroid cancer.
Deal Industry
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Includes Contract
    • Co-Promotion

Related Companies

Advertisement
UsernamePublicRestriction

Register